201 related items for PubMed ID: 2935112
1. [Medroxyprogesterone acetate. Contributive treatment in congenital adrenal hyperplasia caused by 21-hydroxylase deficiency in children].
La Selve H, Sempé M, Morel Y, Forest MG, de Peretti E, David M.
Arch Fr Pediatr; 1985; 42(7):511-6. PubMed ID: 2935112
[Abstract] [Full Text] [Related]
2. [Final height in 69 patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency].
David M, Sempé M, Blanc M, Nicolino M, Forest MG, Morel Y.
Arch Pediatr; 1994 Apr; 1(4):363-7. PubMed ID: 7842090
[No Abstract] [Full Text] [Related]
3. [Value of the assay of plasma steroids in the control of congenital adrenal hyperplasia].
Theintz GE, Sizonenko PC.
Arch Fr Pediatr; 1985 Mar; 42(3):211-7. PubMed ID: 4004483
[Abstract] [Full Text] [Related]
4. [Puberty and growth development in patients with a 21-hydroxylase defect].
Börger D, Willig RP.
Monatsschr Kinderheilkd; 1985 Nov; 133(11):828-33. PubMed ID: 2934617
[Abstract] [Full Text] [Related]
5. [Neglected congenital adrenogenital syndrome (AGS) in an adult. A case report (21-hydroxylase deficiency) with a summary of the current status of therapy with reference to adulthood].
Mackenroth T.
Internist (Berl); 1986 Apr; 27(4):274-8. PubMed ID: 3519519
[No Abstract] [Full Text] [Related]
6. [A clinical study of congenital adrenal hyperplasia].
Nanbu A, Kumamoto Y, Tachiki H, Itoh N, Mikuma N, Tsunekawa T, Takagi Y, Maruta H.
Hinyokika Kiyo; 1989 Nov; 35(11):1831-7. PubMed ID: 2559616
[Abstract] [Full Text] [Related]
7. [Congenital virilizing adrenal hyperplasia due to 11 beta-hydroxylase deficiency. Study of eleven cases (author's transl)].
Dunand A, Roger M, Chaussain JL, Nocton F, Job JC.
Sem Hop; 1989 Nov; 57(33-36):1392-7. PubMed ID: 6270798
[Abstract] [Full Text] [Related]
8. Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Völkl TM, Simm D, Beier C, Dörr HG.
Pediatrics; 2006 Jan; 117(1):e98-105. PubMed ID: 16396852
[Abstract] [Full Text] [Related]
9. [Somatic development in a group of 59 children with congenital adrenal hyperplasia in relation to therapy].
Lisá L.
Cesk Pediatr; 1989 Dec; 44(12):712-3. PubMed ID: 2636554
[Abstract] [Full Text] [Related]
10. Growth patterns and outcomes in congenital adrenal hyperplasia; effect of chronic treatment regimens.
Rasat R, Espiner EA, Abbott GD.
N Z Med J; 1995 Aug 11; 108(1005):311-4. PubMed ID: 7644165
[Abstract] [Full Text] [Related]
11. [11beta-hydroxylase deficiency: improvement of final height with growth hormone and gonadotropin-releasing hormone analog].
Orío Hernández M, Yebra Yebra J, Bezanilla López C, Gracia Bouthelier R.
An Pediatr (Barc); 2007 Aug 11; 67(2):153-6. PubMed ID: 17692261
[Abstract] [Full Text] [Related]
12. Growth and pubertal development in patients with congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency.
Hochberg Z, Schechter J, Benderly A, Leiberman E, Rosler A.
Am J Dis Child; 1985 Aug 11; 139(8):771-6. PubMed ID: 3875277
[Abstract] [Full Text] [Related]
13. Flutamide, testolactone, and reduced hydrocortisone dose maintain normal growth velocity and bone maturation despite elevated androgen levels in children with congenital adrenal hyperplasia.
Merke DP, Keil MF, Jones JV, Fields J, Hill S, Cutler GB.
J Clin Endocrinol Metab; 2000 Mar 11; 85(3):1114-20. PubMed ID: 10720048
[Abstract] [Full Text] [Related]
14. Requirement of mineralocorticoid in congenital adrenal hyperplasia due to 11 beta-hydroxylase deficiency.
Hochberg Z, Benderly A, Kahana L, Zadik Z.
J Clin Endocrinol Metab; 1986 Jul 11; 63(1):36-40. PubMed ID: 3011843
[Abstract] [Full Text] [Related]
15. Modern medical therapy of congenital adrenal hyperplasia. A decade of experience.
Winter JS, Couch RM.
Ann N Y Acad Sci; 1985 Jul 11; 458():165-73. PubMed ID: 3879120
[No Abstract] [Full Text] [Related]
16. [Treatment of true precocious puberty with medroxyprogesterone acetate].
Abodovsky N, Matus de la Parra A, Vivanco X, Onetto E.
Bol Med Hosp Infant Mex; 1979 Jul 11; 36(4):581-97. PubMed ID: 380593
[Abstract] [Full Text] [Related]
17. [Therapeutic problems in the adrenogenital syndrome caused by salt-losing 21-hydroxylase deficiency. Appearance of signs of corticoid overdosage at normally used doses].
Iester A, Fasce L, Cambiaso P, Di Rocco M, Cordone G.
Minerva Pediatr; 1981 Apr 30; 33(8):367-73. PubMed ID: 6972480
[No Abstract] [Full Text] [Related]
18. [Value of medroxyprogesterone acetate in the treatment of precocious puberty].
Hausser C, Schmelk PH, Rappaport R.
Union Med Can; 1983 Jan 30; 112(1):66-8. PubMed ID: 6220501
[No Abstract] [Full Text] [Related]
19. Sex reassignment in a girl with 11 beta-hydroxylase deficiency.
Bistritzer T, Sack J, Eshkol A, Zur H, Katznelson D.
Isr J Med Sci; 1984 Jan 30; 20(1):55-8. PubMed ID: 6607909
[Abstract] [Full Text] [Related]
20. [Growth and puberal development in males with adreno-genital syndrome].
Gargantini L, Calzi P, Brunelli V, Braggion F, Chiumello G.
Pediatr Med Chir; 1989 Jan 30; 11(6):597-602. PubMed ID: 2699925
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
